BIOPHARMA CONGRESS IV

November 14, 2018

 

 

PRESENTED BY PREVISION POLICY + Friends Of Cancer RESEARCH

drug pricing. approval standards. the future fda. Patient Input. 

 

 

2018 CONFIRMED SPEAKERS

HHS DEPUTY SECRETARY ERIC HARGAN

JOSHUA BILENKER (CEO, LOXO ONCOLOGY)

JOE GROGAN (OMB)

DANIEL BEST (HHS)

JOHN O'BRIEN (HHS)

JANET WOODCOCK (CDER)

RICHAR PAZDUR (OCE)

PETER MARKS (CBER)

BOB TEMPLE (CDER)

PETER STEIN (OND)

JAMES SMITH (OND)

 

 

 

LEAD 2018 SPONSOR

 

BIOPHARMA CONGRESS 2018 SPONSORS 

 

agenda

view our agenda of regulators, policy makers, and drug developers

Learn More →

Register

space is limited. register now.

Find Out How →